Non-Alcoholic Fatty Liver Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who were diagnosed with their liver condition before the age of 18.
- People who have been diagnosed with a condition on the NAFLD (non-alcoholic fatty liver disease) spectrum, which can include fat in the liver with or without inflammation or scarring.
- People whose diagnosis was confirmed by an imaging scan (such as an ultrasound) showing fat in the liver, along with tests that ruled out other causes of liver disease, and/or a liver biopsy showing fat affecting more than 5% of the liver in a pattern consistent with childhood-onset fatty liver disease.
Who may not be able to join:
- People whose fatty liver disease is caused by another underlying condition, such as a glycogen storage disorder, Wilson disease, viral hepatitis, a medication, autoimmune hepatitis, or type 1 diabetes.
- People who developed fatty liver disease after receiving an organ transplant.
- People who consume more than 20 grams of alcohol per day (roughly one to two standard drinks, depending on the drink — confirm with trial site).
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: David B Savage, University of Cambridge
Phone: 0044124644
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Survival
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.